|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7045313B1
(en)
|
1982-11-30 |
2006-05-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
JP3282188B2
(ja)
|
1991-06-27 |
2002-05-13 |
日本電気株式会社 |
半導体メモリ装置
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
AU691175B2
(en)
|
1993-03-31 |
1998-05-14 |
Nippon Zeon Co., Ltd. |
Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
WO1995019799A1
(en)
|
1994-01-21 |
1995-07-27 |
Agracetus, Inc. |
Gas driven gene delivery instrument
|
|
GB9502879D0
(en)
|
1995-02-14 |
1995-04-05 |
Oxford Biosciences Ltd |
Particle delivery
|
|
US6265387B1
(en)
|
1995-10-11 |
2001-07-24 |
Mirus, Inc. |
Process of delivering naked DNA into a hepatocyte via bile duct
|
|
US6458560B1
(en)
|
1996-04-05 |
2002-10-01 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
JP2000514290A
(ja)
|
1996-07-01 |
2000-10-31 |
ローヌ―プーラン・ロレ・エス・アー |
組換えアデノウイルスの製造方法
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
WO1999032647A1
(en)
|
1997-12-23 |
1999-07-01 |
Introgene B.V. |
Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
|
|
US7922709B2
(en)
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
US6972013B1
(en)
|
1998-07-13 |
2005-12-06 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
US7608273B2
(en)
|
1998-08-12 |
2009-10-27 |
University Of Western Ontario |
Recombinant lentivirus encoding modified GP 120 signal sequences
|
|
AT408615B
(de)
|
1998-09-15 |
2002-01-25 |
Immuno Ag |
Neue influenzavirus-impfstoffzusammensetzung
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
ATE368122T1
(de)
|
1999-04-29 |
2007-08-15 |
Cell Genesys Inc |
Verfahren und mittel für die herstellung von sicheren rekombinanten lentiviralen vektoren mit hohem titer
|
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
UA82479C2
(uk)
|
2002-05-16 |
2008-04-25 |
Бавариан Нордика А/С |
Міжгенні регіони як сайти вставки в геном модифікованого вірусу коров'ячої віспи ankara (mva)
|
|
WO2004028563A1
(en)
|
2002-09-27 |
2004-04-08 |
Genexine Inc. |
A vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus
|
|
WO2007121194A1
(en)
*
|
2006-04-10 |
2007-10-25 |
The Regents Of The University Of California |
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
|
|
US20080131940A1
(en)
|
2004-06-25 |
2008-06-05 |
Robert Chiu |
Target Cell-Specific Short Interfering Rna and Methods of Use Thereof
|
|
WO2006135436A2
(en)
|
2004-10-22 |
2006-12-21 |
University Of Florida Research Foundation, Inc. |
Inhibition of gene expression and therapeutic uses thereof
|
|
US8048404B1
(en)
|
2005-01-04 |
2011-11-01 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles for protein drug delivery
|
|
US7541046B1
(en)
|
2005-01-04 |
2009-06-02 |
Gp Medical, Inc. |
Nanoparticles for protein drug delivery
|
|
US7611690B2
(en)
|
2005-01-04 |
2009-11-03 |
Gp Medical, Inc. |
Nanoparticles for protein drug delivery
|
|
US8124398B2
(en)
|
2005-04-24 |
2012-02-28 |
Sanofi Pasteur Biologics Co. |
Recombinant flavivirus vaccines
|
|
AR054822A1
(es)
|
2005-07-07 |
2007-07-18 |
Sanofi Pasteur |
Emulsion inmuno adyuvante
|
|
AU2007204879A1
(en)
*
|
2006-01-11 |
2007-07-19 |
Aerovance, Inc. |
Methods and compositions for treating asthma in human and non human primates
|
|
US20090068195A1
(en)
*
|
2007-04-23 |
2009-03-12 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
EP2414520A2
(en)
*
|
2009-03-31 |
2012-02-08 |
Altair Therapeutics, Inc. |
Methods of modulating an immune response to a viral infection
|
|
AU2010269120B2
(en)
*
|
2009-07-06 |
2015-09-24 |
The Australian National University |
Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor
|